ロード中...
Adjuvant Therapy in Renal Cell Carcinoma—Past, Present, and Future()
To date, no effective adjuvant treatment for renal cell carcinoma (RCC) has been described, but research in this area is important since the 5-year relapse rate for intermediate- and high-risk early-stage RCC is 30%–40%. Metastatic RCC can be treated successfully with immune therapy and targeted the...
保存先:
| 主要な著者: | , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
W.B. Saunders
2013
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3765962/ https://ncbi.nlm.nih.gov/pubmed/23972712 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1053/j.seminoncol.2013.05.004 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|